The active form of NMU in humans; binds with high affinity to receptors on human left ventricle and coronary artery (KDs = 0.26 and 0.11 nM, respectively), eliciting endothelium-independent vasoconstriction; suppresses glucose-stimulated insulin secretion in human islets.